PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 …
EPS compared to full-year 2020. QUARTERLY FINANCIAL HIGHLIGHTS (Fourth-Quarter 2021 vs. Fourth-Quarter 2020) Fourth-quarter 2021 revenues totaled $23.8 billion, an increase of $12.2 billion, or 105%, compared to the prior-year quarter, reflecting operational growth of $12.3 billion, or 106%, as well as an unfavorable impact of foreign
Download PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 …
Information
Domain:
Source:
Link to this page:
Documents from same domain
A New Breed of Battery
s28.q4cdn.comPresentation, and accordingly, neither of them expressed an opinion or provided any other form of assurance with respect thereto for the purpose of this Presentation. ... DCRC and Solid Power believe that these non-GAAP financial measures provide useful information to management and investors regarding certain financial and business trends ...
3Q21 Earnings
s28.q4cdn.comGas Production (MMcfpd) Oil Production (MBopd) 393.8 2,363-251.2 582 81.5 645.0 2,945 81.5 Capital Expenditures1 Drilling & Completion Activity $171 $164 $165 $159 $337 $323 Free Cash Flow2 $125 $263 $387 5 3Q21 Operational & Financial Results 3Q21 Core Performance Highlights • Completed the merger between Cabot and Cimarex • Oil production ...
Analyst and Investor Call to
s28.q4cdn.comDec 17, 2021 · potential efficacy against variants and variant specific vaccine development and anticipated manufacturing, distribution, supply, revenue contribution, growth and performance); Pfizer’s investigational oral antiviral candidate PAXLOVID (including qualitative assessments of available data, including interim data,
Patient Manual - s28.q4cdn.com
s28.q4cdn.comThe Senza®, Senza II™ and Senza Omnia™ neuromodulation systems, when programmed to include a frequency of 10 kHz, are indicated as aids in the management of chronic intractable pain of the lower limbs, including unilateral or bilateral pain, associated with diabetic neuropathy.
PFIZER REPORTS THIRD-QUARTER 2021 RESULTS
s28.q4cdn.commanufacturer of EpiPen and other auto-injector products, which had been reported within the results of the Upjohn Business(6) in the first three quarters of 2020, is included within the Hospital therapeutic area for all periods presented. Business development activities completed in 2020 and 2021 impacted financial results in the periods ...
REFINITIV STREETEVENTS EDITED TRANSCRIPT
s28.q4cdn.comJan 10, 2022 · So fact needs, say, to make us alert so that we will be always ahead of the virus. And -- but clearly, the situation is way, way better than what we had when we started, when we didn't even have treatments. Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst Yes, absolutely.
UNITED STATES
s28.q4cdn.comAnnual Report on Form 10-K for the fiscal year ended December 31, 2020 ACIP Advisory Committee on Immunization Practices ALK anaplastic lymphoma kinase Alliance revenues Revenues from alliance agreements under which we co-promote products discovered or developed by other companies or us Allogene Allogene Therapeutics, Inc. Array Array …
To our shareholders, customers,
s28.q4cdn.commission of unleashing the potential of every team. As is the Atlassian way, we set out an ambitious plan, and we executed on it. We played offense throughout this difficult year. We finished fiscal 2021 proud of our resilience and what we accomplished together as a team. Those accomplishments include surpassing
Third Quarter 2021 Earnings Teleconference
s28.q4cdn.comproduct candidates, including anticipated regulatory submissions, data readouts, study starts, approvals, clinical trial result- s and other developing data, ... Cumulative market share is 58.8% in the U.S. and 73.4% in the EU. ... Biosimilars (1) See Slides 38 and 39 for definition of Comirnaty, which is the name for the Pfizer -BioNTech COVID ...
Q2 FY22 | January 27, 2022
s28.q4cdn.comthe trends in our three addressable markets, investing heavily in R&D, playing the long game with our uniquely efficient GTM model, and staying true to our values, Atlassian is delivering a metric tonne of value. Coming off a solid start to the fiscal year, the Atlassian flywheel kept our momentum high and delivered a bonza Q2.
Related documents
Press release Full year and fourth quarter 2020 - GSK
www.gsk.comFull year and fourth quarter 2020 Q4 Results summary Total and Adjusted results YTD performance Quarterly performance Financial information Issued: Wednesday, 3 February 2021, London, U.K. 1 Issued: Wednesday, 3 February 2021, London U.K. GSK delivers FY 2020 reported sales of £34 billion, +1% AER, +3% CER and Adjusted
Sea Limited Reports Fourth Quarter and Full Year 2020 ...
cdn.sea.comMar 02, 2021 · in Southeast Asia for the fourth quarter and for the full year of 2020, according to App Annie3. Free Fire has maintained this leading position for the past six consecutive quarters. o Free Fire was also the highest grossing mobile game in India for the fourth quarter and for the full year of 2020, according to App Annie3.
NIKE, INC. REPORTS FISCAL 2020 FOURTH QUARTER AND …
s1.q4cdn.comfiscal 2020 fourth quarter and full year ended May 31, 2020. • Fourth quarter reported revenues were $6.3 billion, declining from prior year as the majority of NIKE-owned and partner stores in North America, EMEA and APLA were closed due to the COVID-19 pandemic. • NIKE digital sales increased 75 percent in the fourth quarter, or 79 percent ...
Morgan Stanley Fourth Quarter and Full Year 2021 Earnings ...
www.morganstanley.comRecord Full Year Net Revenues of $59.8 Billion, EPS of $8.03 and ROTCE of 19.8% NEW YORK, January 19, 2022 – Morgan Stanley (NYSE: MS) today reported net revenues of $14.5 billion for the fourth quarter ended December 31, 2021 compared with $13.6 billion a year ago.
Meta Reports Fourth Quarter and Full Year 2021 Results ...
s21.q4cdn.comDec 31, 2021 · Fourth Quarter and Full Year 2021 Operational and Other Financial Highlights • Family daily active people (DAP) – DAP was 2.82 billion on average for December 2021, an increase of 8% year-over-year. • Family monthly active people (MAP) – MAP was 3.59 billion as of December 31, 2021, an increase of
Etsy, Inc. Reports Fourth Quarter and Full Year 2021
s22.q4cdn.comDec 31, 2021 · Fourth Quarter and Full Year 2021 Financial Summary (in thousands, except percentages; unaudited) The financial results of Elo7 and Depop have been included in our consolidated financial results from July 2, 2021 and July 12, 2021 (the dates of acquisition), respectively. The GAAP and non-GAAP financial measures and key operating metrics we use ...
PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2020 …
s21.q4cdn.comPFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2020 RESULTS AND RELEASES 5-YEAR PIPELINE METRICS Upjohn Business(1) Now Accounted for as a Discontinued Operation for All Periods Presented, Excluded from Adjusted(2) Results Full-Year 2020 Revenues of $41.9 Billion, Which Now Exclude Upjohn(1), Reflect 3% Operational Growth; When the Impact from …
Novartis Fourth Quarter and Full Year 2021
www.novartis.comNov 03, 2021 · Free cash flow amounted to USD 3.0 billion (–9% USD), compared to USD 3.3 billion in the prior year quarter. Higher operating income adjusted for non-cash items and other adjustments was more than offset by higher income taxes paid and lower divestment proceeds. Full year Net sales Net sales were USD 51.6 billion (+6%, +4% cc) in the full year.